Y-mAbs Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Y-mAbs Therapeutics (YMAB) IPO Opens 67% Higher
September 21, 2018 11:03 AM EDTToday's IPO for Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) opened for tradign at $26.50 after pricing 6,000,000 shares of common stock at a public offering price of $16.00 per share.
In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional... More
